Bromal-derived tetrahydro-β-carbolines as neurotoxic agents: Chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 6, 2000, Pages 1467-1478

  Bringmann, Gerhard ^a   Feineis, Doris ^a   Brückner, Ralph ^a   Blank, Michael ^a   Peters, Karl ^b   Peters, Eva Maria ^b   Reichmann, Heinz ^c   Janetzky, Bernd ^c   Grote, Christoph ^d   Clement, Hans Willi ^d   Wesemann, Wolfgang ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUT FÜR FESTKÖRPERFORSCHUNG   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPTOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; DOPAMINE METABOLISM; MALE; MITOCHONDRIAL RESPIRATION; NEUROTOXICITY; NONHUMAN; POTENTIOMETRY; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; CARBOLINES; CORPUS STRIATUM; DOPAMINE; MALE; MITOCHONDRIA, LIVER; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEUROTOXINS; RATS; RATS, WISTAR; SPECTRUM ANALYSIS; SUBSTANTIA NIGRA;

MAMMALIA;

EID: 18744422932     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00073-0     Document Type: Article

References (55)

1. Airaksinen M.M., Kari I. Med. Biol. 59:1981;190.
2. Buckholtz N. S. Life Sci. 27:1980;893.
3. Brossi, A. In The Alkaloids; Cordell, G. A., Ed.; Academic: San Diego, New York, Berkely, Boston, London, Sydney, Tokyo, Toronto, 1993; Vol. 43, pp 119-183.
4. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I. J. Proc. Natl. Acad. Sci. USA. 80:1983;4546.
5. Singer T.P., Ramsey R.R., Sonsalla P.K., Nicklas W.J., Heikkila R.E. Adv. Neurol. 60:1993;300.
6. Peura P., Kari I., Airaksinen M. Biomed. Mass Spectrom. 7:1980;553.
7. Schouten M.J., Bruinvels J. Anal. Biochem. 147:1985;401.
8. Ohkubo S., Hirano T., Oka K. Lancet. 1:1985;1272.
9. Collins M.A., Neafsey E.J., Cheng B.Y., Hurley-Gius K., Ung-Chhun N.A., Pronger D.A., Christensen M.A., Hurley-Gius D. Adv. Neurol. 45:1986;179.
10. Bringmann G., Hille A. Arch. Pharm. 323:1990;567.
11. Bringmann, G.; Feineis, D.; Grote, C.; God, R.; Clement, H.-W.; Sontag, K.-H.; Janetzky, B.; Reichmann, H.; Rausch, W.-D.; Riederer, P.; Wesemann, W. In Pharmacology of Endogenous Neurotoxins; Moser, A., Ed.; Birkhäuser: Boston, Basel, Berlin, 1998; pp 151-169.
12. Bringmann G., God R., Feineis D., Wesemann W., Riederer P., Rausch W.-D., Reichmann H., Sontag K.-H. J. Neural Transm. 46(Suppl.):1995;235.
13. Bringmann G., God R., Fähr S., Feineis D., Fornadi K., Fornadi F. Anal. Biochem. 270:1999;167.
14. Bringmann G., Feineis D., God R., Fähr S., Wesemann W., Clement H.-W., Grote C., Kolasiewicz W., Sontag K.-H., Heim C., Sontag T.A., Reichmann H., Janetzky B., Rausch W.-D., Abdel-mohsen M., Koutsilieri E., Götz E.M., Gsell W., Zielke B., Riederer P. Biogenic Amines. 12:1996;83.
15. Davis G.C., Williams A.C., Markey S.P., Ebert M.H., Caine E.D., Reichert C.M., Kopin I. J. Psychiatr. Res. 1:1979;249.
16. Sontag, K.-H.; Heim, C.; Sontag, T. A.; Kolasiewicz, W.; Clement, H.-W.; Grote, C.; Wesemann, W.; Janetzky, B.; Reichmann, H.; Feineis, D.; God, R.; Bringmann, G.; Rausch, D.; Abdel-mohsen, M.; Abdel-moneim, M.; Chan, W. W.; Koutsilieri, E.; Zielke, B.; Götz, M.; Gsell, W.; Riederer, P. In The Basal Ganglia V; Ohye, C.; Kimura, M.; McKenzie, J. S., Eds.; Plenum: New York and London, 1996; pp 387-394.
17. Heim C.M., Sontag K.-H. J. Neural Transm. 50:1997;107. (Suppl.).
18. Grote C., Clement H.-W., Wesemann W., Bringmann G., Feineis D., Riederer P., Sontag K.-H. J. Neural Transm. 46(Suppl.):1995;275.
19. Janetzky B., Gille G., Abdel-mohsen M., God R., Rausch W.-D., Bringmann G., Reichmann H. Drug Dev. Res. 46:1999;51.
20. Rausch W.-D., Abdel-Mohsen M., Koutsilieri E., Chan W.W., Bringmann G. J. Neural Transm. 46(Suppl.):1995;255.
21. Janetzky B., God R., Bringmann G., Reichmann H. J. Neural Transm. 46(Suppl.):1995;265.
22. Bringmann G., God R., Feineis D., Janetzky B., Reichmann H. J. Neural Transm. 46(Suppl.):1995;245.
23. Callaway J.C., Gynther J., Poso A., Vepsäläinen J., Airaksinen M.M. J. Heterocyclic Chem. 31:1994;431.
24. Ho B.T., Walker K.E. Org. Synth. 51:1971;136.
25. Hahn G., Bärwald L., Schales O., Werner H. Justus Liebigs Ann. Chem. 520:1935;107.
26. Herbert R.B., Mann J. J. Chem. Soc. Perkin Trans. 1:1982;1523.
27. Maki Y., Kimoto H., Fujii S. J. Fluorine Chem. 35:1987;685.
28. Vlietstra E.J., Zwikker J.W., Nolte R.J.M., Drenth W. J. Roy. Neth. Chem. Soc. 101:1982;460.
29. Peters K., Peters E.-M., Bringmann G., God R. Z. Naturforsch. 50b:1995;1564.
30. Wesemann W., Blaschke S., Solbach M., Grote C., Clement H.-W., Riederer P. J. Neural Transm. 8(PD-Sect.):1994;209.
31. Wesemann W., Grote C., Clement H.-W., Block F., Sontag K.-H. Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:1993;487.
32. Schapira A.H.V., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden J.B. J. Neurochem. 54:1990;823.
33. Mizuno Y., Saitoh T., Sone N. Biochem. Biophys. Res. Commun. 143:1987;971.
34. Albores R., Neafsey E.J., Drucker G., Fields J.Z., Collins M.A. Proc. Natl. Acad. Sci. USA. 87:1990;9368.
35. Fields J.Z., Albores R., Neafsey E.J., Collins M.A. Arch. Biochem. Biophys. 294:1992;539.
36. Ramsay R.R., Singer T.P. J. Biol. Chem. 261:1986;7585.
37. Drucker G., Raikoff K., Neafsey E.J., Collins M.A. Brain Res. 509:1989;125.
38. Bringmann, G.; Brückner, R.; Mössner, R.; Feineis, D.; Heils, A.; Lesch, K.-P. Neurochem. Res. 2000, 25, in press.
39. Gerlach M., Xiao A-Y., Heim C., Lan J., God R., Feineis D., Bringmann G., Riederer P., Sontag K.-H. Neurosci. Lett. 257:1998;17.
40. Bringmann G., Feineis D., Brückner R., Peters E.-M., Peters K. Z. Naturforsch. 55b:2000;94.
41. Akabori S., Saito K. Chem. Ber. 63:1930;2245.
42. Hahn G., Ludewig H. Chem. Ber. 67:1934;2031.
43. Gynther J. Acta Chem. Scand. Ser. B. 42:1988;433.
44. Siemens, P4 X-ray Program System, 1996; Analytical X-ray Instruments Inc., Madison, Wisconsin, USA.
45. Sheldrick, G. M. Program Package SHELXTL-Plus. Release 4.1., Siemens Analytical X-ray Instruments Inc., Madison, Wisconsin, USA, 1990.
46. Keller, E. SCHAKAL 88. A Fortran Program for the Graphic Representation of Molecules and Crystallographic Models; Kristallographisches Institut der Universität Freiburg, Germany, 1990.
47. A complete listing of the atomic coordinates for 12, 13 and 14 can be obtained free of charge, on request, from the Director, Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44-1223-336-033; e-mail: deposit@ccdc.com.ac.uk), on quoting the depository numbers, the names of the authors, and the journal citation.
48. Vallat P., El Tayar N., Testa B., Slacanin I., Marston A., Hostettmann K. J. Chromatogr. 504:1990;411.
49. Slacanin I., Marston A., Hostettmann K. J. Chromatogr. 482:1989;234.
50. El Tayar N., Marston A., Bechalany A., Hostettmann K., Testa B. J. Chromatogr. 469:1989;91.
51. Seiler P. Europ. J. Med. Chem. 9:1974;473.
52. Paxinos, G.; Watson, C. The Rat Brain in Stereotaxic Coordinates; Academic Press: New York, 1982.
53. Grote, C.; Clement, H.-W.; Wesemann, W. In Endocrine and Nutritional Control of Basic Biological Functions; Lehnert, H., Murison, R., Weiner, H., Hellhammer, D., Beyer, J., Eds.; Hogrefe and Huber: Seattle, Toronto, 1993; pp 71-75.
54. Gonon F., Buda M., Cespuglio R., Jouvet M., Pujol J.F. Nature. 286:1980;902.
55. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. J. Biol. Chem. 193:1951;265.